Published in
Elsevier, The Lancet, 10304(398), p. 981-990, 2021
DOI: 10.1016/s0140-6736(21)01699-8
Links
Tools
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
Journal article published in 2021 by
Amy Flaxman,
Natalie G. Marchevsky,
Daniel Jenkin,
Jeremy Aboagye,
Parvinder K. Aley,
Brian Angus,
Sandra Belij-Rammerstorfer,
Sagida Bibi,
Mustapha Bittaye,
Federica Cappuccini,
Paola Cicconi,
Elizabeth A. Clutterbuck,
Sophie Davies,
Wanwisa Dejnirattisai,
Christina Dold 
and other authors.
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 